Pwodwi yo

Faktori nou an bay 2-bromofluorobenzene cas 1072-85-1, N,N-dimethylformamide dimethyl acetal cas 4637-24-5, 5-heptylresorcinol cas 500-67-4. Pwodwi nou yo sitou vann nan kay ak aletranje. Nou te genyen lwanj nan men kliyan ak kalite siperyè, pri rezonab ak sèvis pafè.
View as  
 
  • 1,3-Diethylurea CAS 623-76-7 fè pati baz òganik; ure; blòk bilding òganik; reyaktif jeneral; entèmedyè chimik; materyèl chimik; matyè premyè chimik; entèmedyè chimik

  • 3-Methylpyrazole CAS 1453-58-3 se yon konpoze òganik heterocyclic ki ka itilize kòm yon entèmedyè pharmaceutique.

  • 1,4-Cyclohexanedicarboxylic asid CAS 1076-97-7 se yon kristal blan, idrosolubl nan solvang òganik tankou etanòl, asetòn ak klowofòm. Solibilite a se sou 10%, ak pwen an k ap fonn se 164-167 °C. Trans-1,4-cyclohexanedicarboxylic asid se yon kò Chemicalbook kristal kolon fosfò blan, solubilite nan dlo pi ba pase sa yo ki nan cis, ak pwen an k ap fonn pi wo pase 300 â. Cis-1,4-cyclohexanedicarboxylic asid se yon kristal fèy blan, li gen yon solubility konsiderab nan dlo, e li gen yon pwen k ap fonn nan 170 a 171 °C.

  • Methylthiouracil CAS 56-04-2, alyas Chinwa a nan 6-methyl-2-thiouracil (6-methyl-2-thiouracil), se yon entèmedyè pharmaceutique enpòtan; li pa sèlman gen aktivite anti-bakteri Chemicalbook, men tou, li ka itilize pou trete ipètiwoyid. Li inibit pwodiksyon tiroksin pa anpeche sistèm peroksidaz nan tiwoyid la, kidonk reyalize efè a nan trete ipètiwoyid.

  • 2-Bromo-3-fluoropyridine CAS 40273-45-8 fè pati seri heterocycles polyhalogen-ranplase; piridin; dérivés piridin; entèmedyè piridin; blòk bilding heterocyclic; reyaktif jeneral; entèmedyè pharmaceutique;

  • Nou se yon manifakti dirijan nan 2-(Trifluoromethyl) asid benzoik CAS 433-97-6 nan Lachin.2- (Trifluoromethyl) asid benzoik CAS 433-97-6 ki disponib nan stock epi yo ka delivre byen vit.COA, MSDS ak TDS nan 2-(Trifluorometil) asid benzoik CAS 433-97-6.

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept